AngioDynamics Executive and Leadership Team

Yoel Zabar, the Chief Executive Officer at AngioDynamics, directs the company's overall strategic vision and operational execution. Zabar guides AngioDynamics' mission to develop innovative medical devices that enhance patient outcomes, leveraging the company's established global presence. This leadership role involves aligning departmental objectives with the overarching goal of advancing medical solutions across key healthcare markets worldwide. By fostering strategic partnerships and optimizing distribution networks, Zabar ensures the company's continued contribution to global healthcare improvements. The Chief Executive Officer's purview encompasses driving growth initiatives and maintaining AngioDynamics' reputation as a committed partner to the medical community. Yoel Zabar's strategic direction is fundamental to the company's sustained impact and market leadership.

Joseph Gersuk, the Chief Financial Officer at AngioDynamics, oversees all financial operations and strategic financial planning. Gersuk manages the company's fiscal health, ensuring robust financial controls and driving profitability in alignment with AngioDynamics' mission. This executive function involves resource allocation, budget management, and financial forecasting to support the development of high-quality medical devices. The Chief Financial Officer's responsibilities extend to optimizing financial performance across AngioDynamics' worldwide operations, contributing to its strong presence in key healthcare markets. By providing critical financial insights, Gersuk enables informed decision-making that supports innovation and growth. Joseph Gersuk's financial acumen is vital for sustaining the company's commitment to advancing medical solutions and improving patient outcomes globally.

Stephen Trowbridge, the Executive Vice President & Chief Financial Officer at AngioDynamics, spearheads the company's financial strategy and fiscal management. Trowbridge ensures the financial integrity and operational efficiency supporting AngioDynamics' development of innovative medical devices aimed at improving patient outcomes. This executive role involves comprehensive oversight of financial planning, accounting, and investor relations, crucial for maintaining the company's global presence. The Chief Financial Officer's responsibilities extend to optimizing financial performance across worldwide operations, reinforcing AngioDynamics' position in key healthcare markets. By providing strategic financial guidance, Trowbridge enables the company to pursue growth opportunities and maintain its commitment to advancing medical solutions. Stephen Trowbridge's financial leadership is integral to AngioDynamics' sustained contribution to global healthcare.

Sibabalo Sibabalo, the Group Chief Financial Officer at AngioDynamics, leads the financial operations and strategic fiscal planning for the company's global entities. Sibabalo ensures financial discipline and drives performance optimization across AngioDynamics' diverse business units, supporting the development of high-quality medical devices. This critical role involves managing financial resources, implementing robust controls, and forecasting financial outcomes to align with the company's mission of improving patient outcomes. The Group Chief Financial Officer's oversight extends to all worldwide operations, bolstering AngioDynamics' strong presence in key healthcare markets. By providing strategic financial direction, Sibabalo enables informed decision-making that fuels innovation and growth. Sibabalo Sibabalo's financial expertise is essential for AngioDynamics' continued contribution to advancing medical solutions on a global scale.

Marna Bronfen-Moore, the Senior Vice President, Chief Human Resources Officer at AngioDynamics, directs all human capital strategies and organizational development initiatives. Bronfen-Moore cultivates a high-performance culture that supports AngioDynamics' commitment to innovation and its role as a medical community partner. This leadership position involves talent acquisition, employee engagement, and the development of programs that enhance the skills and well-being of the workforce across worldwide operations. The Chief Human Resources Officer ensures that human resources policies align with the company's mission to improve patient outcomes through high-quality medical devices. By fostering a supportive and dynamic work environment, Bronfen-Moore contributes to the company's strong presence in key healthcare markets. Marna Bronfen-Moore's expertise is crucial for building and retaining the talent necessary for AngioDynamics' continued global success and advancement in medical solutions.

Larry Weiss, the Chief Legal Officer & Corporate Secretary at AngioDynamics, provides comprehensive legal counsel and oversees corporate governance. Weiss ensures that AngioDynamics operates in full compliance with all applicable laws and regulations, safeguarding the company's interests as it develops innovative medical devices. This executive function involves managing all legal affairs, including contracts, litigation, and intellectual property, supporting the company's mission to improve patient outcomes. The Chief Legal Officer's responsibilities extend to advising the board of directors and executive leadership on legal matters pertinent to worldwide operations and market presence. By ensuring legal integrity, Weiss supports AngioDynamics' strong standing in key healthcare markets and its commitment to advancing medical solutions. Larry Weiss's legal acumen is vital for maintaining corporate stability and facilitating AngioDynamics' global growth and operational success.